The Pfizer vaccine COVID-19 is causing allergic reactions at a higher rate than “ what one would expect from ” other shots, says the chief scientific advisor for Warp Speed.

  • Dr. Moncef Al-Salawi said that the last time he was informed of allergic reactions was on Tuesday, as there were six cases.
  • “This hesitation, as it was yesterday, is better than one would expect with other vaccines,” he said
  • There are discussions between vaccine makers and the National Institutes of Health to consider clinical trials of vaccines in hypersensitive groups
  • The potential study may look into vaccines made by Pfizer and Moderna, although only reactions have been reported by people who have gotten the Pfizer injection.

The chief scientific advisor for Operation Warp Speed ​​said Wednesday that the frequency of allergic reactions to the COVID-19 vaccine from Pfizer is “ better ” than we usually see from other vaccines.

Dr. Moncef Al-Salawi said that the last time he was informed of allergic reactions was on Tuesday, as there were six cases, CNN mentioned.

“This hesitation, as it was yesterday, is better than one would expect with other vaccines,” he said.

Dr. Moncef Al-Salawi said that the last time he was informed of allergic reactions was last Tuesday, as there were six cases of allergic reactions.

Dr Al-Salawi indicated that the data on Coronavirus vaccinations lag behind the actual figures.

He added that there are discussions between vaccine makers and the National Institutes of Health to consider clinical trials of vaccines in populations with severe allergies, preferably those who carry an EpiPen with them.

See also  Coronavirus in Great Britain. Johnson is accused of breaking the restrictions

Dr El-Slaoui said that conducting the experiment can help understand what triggers the allergic reactions.

On Monday, an official with the National Institute of Allergy and Infectious Diseases said CNBC The United States is investigating why people experience severe allergic reactions after getting the COVID-19 vaccine.

There are discussions between vaccine makers and the National Institutes of Health to consider clinical trials of vaccines in hypersensitive groups

There are discussions between vaccine makers and the National Institutes of Health to consider clinical trials of vaccines in hypersensitive groups

A study is currently in the early planning stages and is expected to include “several hundreds” of people with a history of severe allergic reactions, according to Alex Togias, chair of the Allergy, Asthma and Airway Biology Branch at NIAID.

His department will run the study, which we hope will start in the coming weeks.

The study may look at vaccines made by Pfizer and Moderna, although reactions have only been reported by people who have gotten the Pfizer injection.

A healthcare worker in New York City has become the sixth known person to have experienced a “severe” allergic reaction to the COVID-19 vaccine.

Two British healthcare workers developed anaphylactic shock when they received it in the first week of its distribution, and three in Alaska also suffered similar reactions.

More than 30,000 COVID-19 vaccines have been given in New York City and they are the only person known to have had a reaction.